Literature DB >> 2758390

Cancer risk in male veterans utilizing the Veterans Administration medical system.

R E Harris1, J R Hebert, E L Wynder.   

Abstract

Age-specific incidence curves, cumulative rates, and relative risks were estimated for selected malignancies among male veterans utilizing the Veterans Administration (VA) medical system during 1970 to 1982. Relative risks for malignant tumors of the lung, bronchus, larynx, oral cavity, and esophagus in males using VA hospitals were approximately double the rates for men of the Surveillance, Epidemiology, and End Results (SEER) cancer registry, thereby supporting the existence of strong effects of chronic cigarette smoking and alcohol consumption on the development of neoplasms at these specific anatomic sites. Relative to the SEER male population, there were significant reductions in the cumulative rates of neoplasms of the colon (15%) and extrahepatic biliary tract (30%), no differences in the rates of cancer of the stomach, small intestine, or pancreas, and a 50% increase in the cumulative rate of liver cancer among the veterans. Rates of malignancies of the genitourinary tract were similar in the VA and SEER registries with the exception of cancer of the penis, for which the cumulative rate was 50% higher in the veterans. These results are consistent with an excess of specific risk exposures among male veterans using VA hospitals, viz., cigarette smoking, alcohol consumption, poor nutrition, and other factors related to low socioeconomic status. The ultimate utility of the VA tumor registry will depend upon its exploitation by epidemiologists to provide leads for etiologic research.

Entities:  

Mesh:

Year:  1989        PMID: 2758390     DOI: 10.1002/1097-0142(19890901)64:5<1160::aid-cncr2820640533>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Substance abuse in military personnel: better or worse?

Authors:  L I Gardner
Journal:  Am J Public Health       Date:  1991-07       Impact factor: 9.308

2.  Attitudes and beliefs toward lung cancer screening among US Veterans.

Authors:  Nichole T Tanner; Leonard E Egede; Clayton Shamblin; Mulugeta Gebregziabher; Gerard A Silvestri
Journal:  Chest       Date:  2013-12       Impact factor: 9.410

3.  Comparing the smoking behavior of veterans and nonveterans.

Authors:  W P McKinney; D D McIntire; T J Carmody; A Joseph
Journal:  Public Health Rep       Date:  1997 May-Jun       Impact factor: 2.792

4.  Poor survival for veterans with pathologic stage I non-small-cell lung cancer.

Authors:  Jamii B St Julien; Rhonda Pinkerman; Melinda C Aldrich; Heidi Chen; Stephen A Deppen; Carol Callaway-Lane; Pierre Massion; Joe B Putnam; Eric S Lambright; Jonathan C Nesbitt; Eric L Grogan
Journal:  Am J Surg       Date:  2012-08-18       Impact factor: 2.565

5.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

6.  Increased cumulative incidence of prostate malignancies in colorectal cancer patients.

Authors:  Nuri Ozden; Murat Saruc; Lynette M Smith; Arthi Sanjeevi; Hemant K Roy
Journal:  Int J Gastrointest Cancer       Date:  2003

7.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

8.  Patient preference and contraindications in measuring quality of care: what do administrative data miss?

Authors:  Joan J Ryoo; Diana L Ordin; Anna Liza M Antonio; Sabine M Oishi; Michael K Gould; Steven M Asch; Jennifer L Malin
Journal:  J Clin Oncol       Date:  2013-06-10       Impact factor: 44.544

9.  Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbidities.

Authors:  Keith Sigel; Chung Yin Kong; Sadiq Rehmani; Susan Bates; Michael Gould; Kimberly Stone; Minal Kale; Yeun-Hee Park; Kristina Crothers; Faiz Bhora; Juan Wisnivesky
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

10.  Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population.

Authors:  Lixia Fan; Linqi Chen; Xiaoling Ni; Shicheng Guo; Yinghui Zhou; Chenji Wang; Yabiao Zheng; Fangyuan Shen; Vijay Kumar Kolluri; Merlin Muktiali; Zhenhong Zhao; Junjie Wu; Dunmei Zhao; Zhenglei He; Xulong Feng; Ziyu Yuan; Juan Zhang; Li Jin; Jiucun Wang; Minghua Wang
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.